ScoreWhy is Acutaas Chemicals Ltd ?
1
Company has a Debt to Equity ratio (avg) of 0.05 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 30.30% and Operating profit at 43.36%
3
The company has declared Positive results for the last 8 consecutive quarters
- PAT(Latest six months) At Rs 206.02 cr has Grown at 92.96%
- NET SALES(Latest six months) At Rs 762.42 cr has Grown at 47.84%
- ROCE(HY) Highest at 28.77%
4
With ROE of 21.5, it has a Very Expensive valuation with a 16 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of NA, its profits have risen by 104.3% ; the PEG ratio of the company is 0.7
5
High Institutional Holdings at 41.17%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 2.07% over the previous quarter.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Acutaas Chemical should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
30.30%
EBIT Growth (5y)
43.36%
EBIT to Interest (avg)
61.25
Debt to EBITDA (avg)
0.27
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.86
Tax Ratio
26.72%
Dividend Payout Ratio
7.74%
Pledged Shares
0
Institutional Holding
41.17%
ROCE (avg)
20.10%
ROE (avg)
14.51%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
69
Industry P/E
44
Price to Book Value
16.01
EV to EBIT
52.06
EV to EBITDA
48.44
EV to Capital Employed
17.95
EV to Sales
17.98
PEG Ratio
0.66
Dividend Yield
0.05%
ROCE (Latest)
30.35%
ROE (Latest)
21.54%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
PAT(Latest six months)
At Rs 206.02 cr has Grown at 92.96%
NET SALES(Latest six months)
At Rs 762.42 cr has Grown at 47.84%
ROCE(HY)
Highest at 28.77%
INVENTORY TURNOVER RATIO(HY)
Highest at 5.79 times
-3What is not working for the Company
PAT(Q)
At Rs 74.26 cr has Fallen at -16.6% (vs previous 4Q average
PBT LESS OI(Q)
At Rs 102.11 cr has Fallen at -7.4% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Acutaas Chemical
Net Sales - Latest six months
At Rs 762.42 cr has Grown at 47.84%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Inventory Turnover Ratio- Half Yearly
Highest at 5.79 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Acutaas Chemical
Profit After Tax (PAT) - Quarterly
At Rs 74.26 cr has Fallen at -16.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 89.06 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 102.11 cr has Fallen at -7.4% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 110.29 CrMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
